Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The available data indicate that ETBE was without effect on complement and anti-body-dependent aspects of immunization in the rat, with a sub-acute (28-day) NOAEL of 1000 mg/kg bw/day, the highest dose tested.

Key value for chemical safety assessment

Additional information

T-cell dependent antibody responses (assessed using a splenic antibody-forming cell assay) were determined in female rats administered ETBE by oral gavage at treatment levels up to 1000 mg/kg bw/day for 28-days (WIL Research Laboratories, 2010; Banton et al., 2011). The study was guideline (OPPTS 870.7800) and GLP-compliant, and measured the activity of IgM antibody-forming cells produced following immunisation with sheep red blood cells. No difference in spleen cell numbers or reduction in the IgM antibody-forming cell response was observed relative to that measured in untreated controls, whereas the positive control substance (cyclophosphamide) resulted in statistically significant decreases in mean spleen cell numbers with no detectable antibody-forming response present. This assay demonstrates that ETBE was without effect on complement and antibody-dependent aspects of immunization (NOAEL = 1000 mg/kg bw/day p.o.).

Justification for classification or non-classification

In accordance to Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008, no classification is necessary.